secwatch.observer — SEC 8-K summary
======================================

Issuer:     Outlook Therapeutics, Inc. (OTLK)
CIK:        0001649989
Form:       8-K
Filed at:   2026-04-23T23:59:59+00:00
Accession:  0001104659-26-047741
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Outlook Therapeutics raises ~$5M in registered direct offering and private placement at $0.31/unit
--------------------------------------------------------------------------------

- Offering of 16,129,033 shares of common stock and accompanying Common Warrants at $0.31 per unit.
- Gross proceeds approximately $5.0 million; net proceeds for working capital and general corporate purposes.
- Common Warrants exercisable at $0.31 per share, subject to stockholder approval and increase in authorized shares.
- Concurrent warrant amendment reduces exercise price of 2,142,854 existing warrants from $2.26 to $0.31.
- H.C. Wainwright acted as placement agent with 7.0% cash fee and warrants for 1,129,032 shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1649989/000110465926047741/0001104659-26-047741-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1649989/000110465926047741/tm2612578d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-047741

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer